PubMed

Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race.

Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG.

Ann Intern Med. 2003 Jun 17;138(12):960-8.PMID: 12809452 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, Plouffe JF, Cetron MS, Butler JC.

JAMA. 1997 Oct 22-29;278(16):1333-9. Erratum in: JAMA 2000 Jan 19;283(3):341. PMID: 9343464 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Hornberger J, Robertus K.

Ann Intern Med. 2006 Sep 5;145(5):317-25.PMID: 16954357 [PubMed - indexed for MEDLINE]Related articlesFree article

[Cost effectiveness of vaccination against pneumococcal bacteremia in the elderly: the results in Belgium]

De Graeve D, Verhaegen J, Ament A, Baltussen R.

Acta Clin Belg. 2000 Sep-Oct;55(5):257-65. Dutch. PMID: 11109640 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.PMID: 17909207 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients.

Middleton DB, Lin CJ, Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS, Fox DE.

Infect Control Hosp Epidemiol. 2008 May;29(5):385-94.PMID: 18521990 [PubMed - indexed for MEDLINE]Related articles

A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.

Asensi F, De Jose M, Lorente M, Moraga F, Ciuryla V, Arikian S, Casciano R, Vento M.

Value Health. 2004 Jan-Feb;7(1):36-51.PMID: 14720129 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.

Postma MJ, Heijnen ML, Jager JC.

Pharmacoeconomics. 2001;19(2):215-22.PMID: 11284385 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.

Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.

Vaccine. 2006 Jul 17;24(29-30):5690-9. Epub 2006 May 5.PMID: 16735083 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany.

Claes C, Graf von der Schulenburg JM.

Pharmacoeconomics. 2003;21(8):587-600.PMID: 12751916 [PubMed - indexed for MEDLINE]Related articles

Visual screening for malignant melanoma: a cost-effectiveness analysis.

Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA.

Arch Dermatol. 2007 Jan;143(1):21-8.PMID: 17224538 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of pneumococcal conjugate vaccination in Australia.

Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.

Vaccine. 2004 Mar 12;22(9-10):1138-49.PMID: 15003641 [PubMed - indexed for MEDLINE]Related articles

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

Eddy DM, Schlessinger L, Kahn R.

Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.

Mangtani P, Roberts JA, Hall AJ, Cutts FT.

Int J Epidemiol. 2005 Jun;34(3):565-74. Epub 2005 Mar 11.PMID: 15764694 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.

[No authors listed]

JAMA. 1998 Nov 25;280(20):1757-63. Erratum in: JAMA 1999 Jan 27;281(4):325. PMID: 9842951 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of screening the U.S. blood supply for West Nile virus.

Custer B, Busch MP, Marfin AA, Petersen LR.

Ann Intern Med. 2005 Oct 4;143(7):486-92.PMID: 16204161 [PubMed - indexed for MEDLINE]Related articlesFree article

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.PMID: 17146064 [PubMed - indexed for MEDLINE]Related articlesFree article

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.PMID: 16545207 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands.

Bos JM, Rümke H, Welte R, Postma MJ.

Clin Ther. 2003 Oct;25(10):2614-30.PMID: 14667962 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team.

Pediatrics. 2005 May;115(5):1220-32.PMID: 15867028 [PubMed - indexed for MEDLINE]Related articlesFree article